Occurrence of Clostridium perfringens β2-toxin amongst animals, determined using genotyping and subtyping PCR assays

Clostridium perfringens isolates are currently classified into one of five biotypes on the basis of the differential production of α-, β-, ε- and ι-toxins. Different biotypes are associated with different diseases of man and animals. In this study a multiple PCR assay was developed to detect the genes encoding these toxins. In addition, detection of the genes encoding the C. perfringens enterotoxin and β2-toxin allowed subtyping of the bacteria. C. perfringens isolates taken from a variety of animals, including foals, piglets or lambs, were genotyped using this assay. Most of the isolates were found to be genotype A and the gene encoding β-toxin was present in 50% of the isolates genotyped. A significant association between C. perfringens possessing the β2-toxin gene and diarrhoea in piglets was identified, suggesting that β2-toxin may play a key role in the pathogenesis of the disease.

[1]  Michel Popoff,et al.  Prevalence of β2-Toxigenic Clostridium perfringens in Horses with Intestinal Disorders , 1999, Journal of Clinical Microbiology.

[2]  K. Morgan,et al.  Case control study of diarrhoea and faecal soiling in two to six-month-old lambs , 1998, Veterinary Record.

[3]  D. L. Harris,et al.  Multiplex PCR assay for detection of Clostridium perfringens in feces and intestinal contents of pigs and in swine feed. , 1998, Veterinary microbiology.

[4]  J. Wood,et al.  Molecular analysis of the virulence determinants of Clostridium perfringens associated with foal diarrhoea. , 1998, Veterinary journal.

[5]  M. Gibert,et al.  Beta2 toxin, a novel toxin produced by Clostridium perfringens. , 1997, Gene.

[6]  J. Songer,et al.  Multiplex polymerase chain reaction assay for genotyping Clostridium perfringens. , 1997, American journal of veterinary research.

[7]  Y. Park,et al.  Molecular typing and epidemiological survey of prevalence of Clostridium perfringens types by multiplex PCR , 1997, Journal of clinical microbiology.

[8]  A. Moir,et al.  The Level of Expression of α-toxin by Different Strains ofClostridium perfringensis Dependent on Differences in Promoter Structure and Genetic Background , 1996 .

[9]  J. Songer Clostridial enteric diseases of domestic animals , 1996, Clinical microbiology reviews.

[10]  B. McClane,et al.  Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens , 1994, Journal of clinical microbiology.

[11]  C. Hatheway,et al.  Toxigenic clostridia , 1990, Clinical Microbiology Reviews.

[12]  W. Grove Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[13]  C. Gardell Diagnostic Procedures in Veterinary Bacteriology and Mycology. , 1980 .

[14]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[15]  S. Cole,et al.  Structure, Organization and Evolution of the Genome of Clostridium perfringens , 1997 .

[16]  J. Songer,et al.  Human disease associated with Clostridium perfringens enterotoxin. , 1997, Reviews of environmental contamination and toxicology.

[17]  B. McClane,et al.  The clostridia: molecular biology and pathogenesis , 1997 .

[18]  G. R. Carter,et al.  Diagnostic procedures in veterinary bacteriology and mycology , 1979 .